Omega Fund V Amends Nuvation Bio Stake
Ticker: NUVB · Form: SC 13D/A · Filed: Oct 18, 2024 · CIK: 1811063
Sentiment: neutral
Topics: schedule-13d, amendment, shareholder-filing
Related Tickers: NUVB
TL;DR
Omega Fund V just updated their Nuvation Bio filing. Watch this space.
AI Summary
Omega Fund V, L.P., along with Otello Stampacchia and Claudio Nessi, filed an amendment (No. 2) to their Schedule 13D on October 18, 2024, regarding their holdings in Nuvation Bio Inc. The filing indicates a change in the group's beneficial ownership of the company's Class A Common Stock.
Why It Matters
This amendment signals a potential shift in the control or investment strategy of a significant shareholder in Nuvation Bio, which could influence the company's future direction.
Risk Assessment
Risk Level: medium — Schedule 13D filings often precede significant corporate actions or changes in control, introducing uncertainty.
Key Players & Entities
- Omega Fund V, L.P. (company) — Filing entity
- Otello Stampacchia (person) — Filing entity
- Claudio Nessi (person) — Filing entity
- Nuvation Bio Inc. (company) — Subject company
FAQ
What specific changes are detailed in Amendment No. 2 to the Schedule 13D?
The filing is an amendment to a previous Schedule 13D, indicating a change in the group's beneficial ownership of Nuvation Bio Inc. The exact nature of the change is not detailed in the provided header information.
Who are the primary individuals and entities involved in this filing?
The filing involves Omega Fund V, L.P., Otello Stampacchia, and Claudio Nessi as the reporting persons, and Nuvation Bio Inc. as the subject company.
When was this amendment filed with the SEC?
This amendment was filed on October 18, 2024.
What is the CUSIP number for Nuvation Bio Inc.'s Class A Common Stock?
The CUSIP number for Nuvation Bio Inc.'s Class A Common Stock is 67080N 101.
What is the business address of Omega Fund V, L.P. as listed in the filing?
The business address for Omega Fund V, L.P. is 888 Boylston St., Suite 1111, Boston, MA 02199.
Filing Stats: 2,584 words · 10 min read · ~9 pages · Grade level 8.1 · Accepted 2024-10-18 16:15:55
Filing Documents
- d892626dsc13da.htm (SC 13D/A) — 104KB
- 0001193125-24-239642.txt ( ) — 106KB
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: October 18, 2024 OMEGA FUND V, L.P. BY: Omega Fund V GP, L.P. ITS: GENERAL PARTNER BY: Omega Fund V GP Manager, Ltd. ITS: GENERAL PARTNER By: /s/ * Deirdre A. Cunnane, as Attorney-in-Fact Director OMEGA FUND V GP, L.P. BY: Omega Fund V GP Manager, Ltd. ITS: GENERAL PARTNER By: /s/ * Deirdre A. Cunnane, as Attorney-in-Fact Director OMEGA FUND V GP MANAGER, LTD. By: /s/ * Deirdre A. Cunnane, as Attorney-in-Fact Director /s/ * Deirdre A. Cunnane, as Attorney-in-Fact Claudio Nessi /s/ * Deirdre A. Cunnane, as Attorney-in-Fact Otello Stampacchia